J-Lex

Levetiracetam tablets 250 mg “Sawai”

Code1139010F1075
Standard250mg x 1 tablet
Ingredient Levetiracetam
Maker Sawai Pharmaceutical

Levetiracetam tablets 250 mg “Sawai” by Sawai Pharmaceutical contains levetiracetam, an antiepileptic drug indicated for the adjunctive treatment of partial onset, myoclonic, and primary generalized tonic-clonic seizures. The standard is 250mg per tablet, with YJ code 1139010F1075.

← Back to search

Need more detailed information?

Contact TASAKI PHARMA for inquiries about this medicine (English support available).

More with the same ingredient

Levetiracetam tablets 250 mg “Sawai”

Need more detailed information?

More with the same ingredient

E Keppra IV infusion 500mg

Levetiracetam IV infusion 500mg “Amel”

Levetiracetam IV infusion 500mg “Nissin”

Levetiracetam IV infusion 500mg “Meiji”

Levetiracetam DS 50% “Towa”

Levetiracetam Dry Syrup 50% “Nichi-Iko”

Levetiracetam Dry Syrup 50% “Nissin”

Levetiracetam Dry Syrup 50% “Meiji”

More from this manufacturer

Felbinac Pap 70mg “Sawai”

Clindamycin Phosphate Ester Gel 1% “Sawai”

Tulobuterol Tape 2mg “SAWAI”

Tulobuterol Tape 1mg “SAWAI”

Tulobuterol Tape 0.5mg “Sawai”

Sodium cromoglycate inhalation solution 1% “SAWAI”

Isosorbide dinitrate tape 40mg “Sawai”

Fluticasone nasal spray 50μg “Sawai” 56 sprays

For Healthcare Professionals